eISSN: 1897-4317
ISSN: 1895-5770
Gastroenterology Review/Przegląd Gastroenterologiczny
Current issue Archive Manuscripts accepted About the journal Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
6/2010
vol. 5
 
Share:
Share:
more
 
 
abstract:
Review paper

Clinical aspects of sodium butyrate application in dietary treatment of bowel diseases

Tomasz Banasiewicz, Katarzyna Borycka-Kiciak, Agnieszka Dobrowolska-Zachwieja, Jerzy Friediger, Adam Kiciak, Piotr Krokowicz, Ewa Małecka-Panas, Piotr Pietrzak, Grażyna Rydzewska, Wiesław Tarnowski, Romuald Zabielski

Przegląd Gastroenterologiczny 2010; 5 (6): 329–334
Online publish date: 2010/12/08
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
This article presents the point of view of a group of experts in physiology, gastroenterology and surgery regarding effectiveness of butyric acid preparation in dietary treatment in patients with small and large bowel diseases. The literature review revealed that butyric acid given per os as sodium salt (sodium butyrate) has a number of beneficial effects on function and regeneration of intestines. The dietary product of special medicinal use Debutir™ (Polfa-Łódź) contains sodium butyrate as an active substance, protected in a triglyceride matrix, which allows slow release of sodium butyrate along the entire gastrointestinal tract, thereby permitting its positive effects to be exerted on the entire small and large bowel. Experts have pointed out the clinical need to introduce butyric acid and its salt in dietary treatment in patients with intestine diseases. Experts have specified several groups of patients who would gain special benefits from enriching the diet with butyric acid. Use of butyric acid preparations is recommended for elderly people, and for patients with irritable bowel disease (IBD), after intestine resection and pouchitis. The strong trophic effect of sodium butyrate justifies its use in patients with cancer cachexia, with chronic diseases and immunity disturbances.
keywords:

sodium butyrate, Crohn’s disease, irritable bowel syndrom

Quick links
© 2018 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe